BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

38 related articles for article (PubMed ID: 22988701)

  • 1. Cellular Responses to Extracellular Vesicles as Potential Markers of Colorectal Cancer Progression.
    Guarnerio S; Tempest R; Maani R; Hunt S; Cole LM; Le Maitre CL; Chapple K; Peake N
    Int J Mol Sci; 2023 Nov; 24(23):. PubMed ID: 38069076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postmenopausal women in gynecological care.
    Pertyńska-Marczewska M; Pertyński T
    Prz Menopauzalny; 2021 Jun; 20(2):88-98. PubMed ID: 34321987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival of colorectal cancer patients in Brunei Darussalam: comparison between 2002-09 and 2010-17.
    Lee SHF; Abdul Rahman H; Abidin N; Ong SK; Leong E; Naing L
    BMC Cancer; 2021 Apr; 21(1):477. PubMed ID: 33926405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determining the Risk Factors Affecting on Death Due to Colorectal Cancer Progression: Survival Analysis in the Presence of Competing Risks.
    Safari M; Mahjub H; Esmaeili H; Abbasi M; Roshanaei G
    J Gastrointest Cancer; 2022 Jun; 53(2):348-355. PubMed ID: 33656691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. S100A16 suppresses the proliferation, migration and invasion of colorectal cancer cells in part via the JNK/p38 MAPK pathway.
    Ou S; Liao Y; Shi J; Tang J; Ye Y; Wu F; Wang W; Fei J; Xie F; Bai L
    Mol Med Rep; 2021 Feb; 23(2):. PubMed ID: 33355370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-Tumor Activity of Atractylenolide I in Human Colon Adenocarcinoma In Vitro.
    Chan KWK; Chung HY; Ho WS
    Molecules; 2020 Jan; 25(1):. PubMed ID: 31947901
    [No Abstract]   [Full Text] [Related]  

  • 7. A symptom-based model to predict colorectal cancer in low-resource countries: Results from a prospective study of patients at high risk for colorectal cancer.
    Alatise OI; Ayandipo OO; Adeyeye A; Seier K; Komolafe AO; Bojuwoye MO; Afuwape OO; Zauber A; Omisore A; Olatoke S; Akere A; Famurewa O; Gonen M; Irabor DO; Kingham TP
    Cancer; 2018 Jul; 124(13):2766-2773. PubMed ID: 29645077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evolving notions on immune response in colorectal cancer and their implications for biomarker development.
    Grizzi F; Basso G; Borroni EM; Cavalleri T; Bianchi P; Stifter S; Chiriva-Internati M; Malesci A; Laghi L
    Inflamm Res; 2018 May; 67(5):375-389. PubMed ID: 29322204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Profiles of differentially expressed genes and overexpression of NEBL indicates a positive prognosis in patients with colorectal cancer.
    Qiu X; Feng JR; Wang F; Chen PF; Chen XX; Zhou R; Chang Y; Liu J; Zhao Q
    Mol Med Rep; 2018 Feb; 17(2):3028-3034. PubMed ID: 29257257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LASP2 suppresses colorectal cancer progression through JNK/p38 MAPK pathway meditated epithelial-mesenchymal transition.
    Wang B; Zhang L; Zhao L; Zhou R; Ding Y; Li G; Zhao L
    Cell Commun Signal; 2017 Jun; 15(1):21. PubMed ID: 28606091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Colorectal cancer patients exhibit increased levels of galanin in serum and colon tissues.
    Kwiatkowski P; Godlewski J; Kieżun J; Kraziński BE; Kmieć Z
    Oncol Lett; 2016 Nov; 12(5):3323-3329. PubMed ID: 27899999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Familial risk of colorectal cancer in subjects attending an organised screening programme.
    Castiglione G; Visioli CB; Zappa M; Grazzini G; Mallardi B; Mantellini P
    Dig Liver Dis; 2012 Jan; 44(1):80-3. PubMed ID: 21925983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improving detection of colorectal cancer.
    Orbell J; West NJ
    Practitioner; 2010 Oct; 254(1733):17-21, 2-3. PubMed ID: 21141248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High yield of colorectal neoplasia detected by colonoscopy following a positive faecal occult blood test in the NHS Bowel Cancer Screening Programme.
    Lee TJ; Clifford GM; Rajasekhar P; Rutter MD; Kometa S; Ritchie MC; Waddup G; Nylander D; McNally RJ; Rees CJ
    J Med Screen; 2011; 18(2):82-6. PubMed ID: 21852700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic inflammatory bowel disease and cancer.
    Pohl C; Hombach A; Kruis W
    Hepatogastroenterology; 2000; 47(31):57-70. PubMed ID: 10690586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early diagnosis improves survival in colorectal cancer.
    Keane MG; Johnson GJ
    Practitioner; 2012; 256(1753):15-8, 2. PubMed ID: 22988701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.